<SEC-DOCUMENT>0001193125-23-097065.txt : 20230411
<SEC-HEADER>0001193125-23-097065.hdr.sgml : 20230411
<ACCEPTANCE-DATETIME>20230411060649
ACCESSION NUMBER:		0001193125-23-097065
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20230411
FILED AS OF DATE:		20230411
DATE AS OF CHANGE:		20230411

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUTEP Ltd
		CENTRAL INDEX KEY:			0001506184
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35428
		FILM NUMBER:		23812317

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 12, 95 PITT STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		612 9276 1224

	MAIL ADDRESS:	
		STREET 1:		LEVEL 12, 95 PITT STREET
		CITY:			SYDNEY, NEW SOUTH WALES
		STATE:			C3
		ZIP:			2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prima BioMed Ltd
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d476110d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated April 11, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number 001-35428 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>IMMUTEP
LIMITED </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name as Specified in its Charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of
Registrant&#146;s Name) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Level 33, Australia Square </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>264 George Street, Sydney </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NSW 2000, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#147;Yes&#148; is marked, indicated below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description&nbsp;of&nbsp;Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><A HREF="d476110dex991.htm">Immutep Announces Changes to the Board </A></P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: April 11, 2023 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">IMMUTEP LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marc Voigt</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Marc Voigt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d476110dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g476110snap1.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g476110snap5.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ASX/Media Release </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Immutep Announces Changes to the Board </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SYDNEY, AUSTRALIA &#150; 11</B><B></B><B>&nbsp;April </B><B>2023 &#150;</B> Immutep Limited (ASX: IMM; NASDAQ: IMMP) (&#147;Immutep&#148; or &#147;the
Company&#148;), a clinical-stage biotechnology company developing novel <FONT STYLE="white-space:nowrap">LAG-3</FONT> immunotherapies for cancer and autoimmune diseases, today announces that Lis Boyce has been appointed as <FONT
STYLE="white-space:nowrap">Non-Executive</FONT> Director. She replaces Lucy Turnbull who <FONT STYLE="white-space:nowrap">re-joined</FONT> the board after the sudden and untimely death of Grant Chamberlain in January 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms Boyce is a highly experienced corporate lawyer. She is currently a partner at Piper Alderman and was previously a partner at Dentons, having been at
DibbsBarker for nearly 30 years. She has extensive involvement in the Life Sciences and Healthcare sectors and is currently deputy chair of AusBiotech&#146;s AusMedtech Advisory Group and a member of AusBiotech&#146;s NSW Leadership Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr Russell Howard, chair of Immutep said: &#147;We are delighted to have Lis join our board. She brings a wealth of industry knowledge and expertise in
capital raisings, strategic collaborations, corporate governance, and mergers and acquisitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the Board, I would like to thank Lucy
Turnbull for stepping in under such tragic and unusual circumstances and for her boundless energy and valued insights.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Immutep </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immutep is a clinical-stage biotechnology company developing novel <FONT STYLE="white-space:nowrap">LAG-3</FONT> immunotherapy for cancer and autoimmune
disease. We are pioneers in the understanding and advancement of therapeutics related to Lymphocyte Activation <FONT STYLE="white-space:nowrap">Gene-3</FONT> <FONT STYLE="white-space:nowrap">(LAG-3),</FONT> and our diversified product portfolio
harnesses its unique ability to stimulate or suppress the immune response. Immutep is dedicated to leveraging its expertise to bring innovative treatment options to market for patients in need and to maximise value for shareholders. For more
information, please visit www.immutep.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Australian Investors/Media: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saskia West, Citadel-MAGNUS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+61 (0)452 120 192;
swest@citadelmagnus.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Investors/Media: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chris
Basta, VP, Investor Relations and Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 (631) 318 4000; chris.basta@immutep.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement was authorised for release by the Board of Immutep Limited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Immutep Limited</B>, Level&nbsp;33, Australia Square, 264 George Street, Sydney NSW 2000, Australia </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ABN: 90 009 237 889 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g476110snap1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g476110snap1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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ME3]WI0!E>$/VRM?\(>%O#GA6U\':!>VWA[1=-T:"]?5KV)[B+3[2*V2=XUA
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MTQ0 8'H..1QTH , =L?ITH   .@Q].* %P/3IS]"./Y4 ( !T &..!C '04
C+0 F!Z#C],4 +0 =/;'X8Q0 =/;'X8H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g476110snap5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g476110snap5.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MWX>_[ZU/_P"2J/[;G_SZ7_DP?ZZXO_H'I?\ @4_\P_X:H\7?]"WX>_[ZU/\
M^2J/[;G_ ,^E_P"3!_KKB_\ H'I?^!3_ ,P_X:H\7?\ 0M^'O^^M3_\ DJC^
MVY_\^E_Y,'^NN+_Z!Z7_ (%/_,/^&J/%W_0M^'O^^M3_ /DJC^VY_P#/I?\
MDP?ZZXO_ *!Z7_@4_P#,/^&J/%W_ $+?A[_OK4__ )*H_MN?_/I?^3!_KKB_
M^@>E_P"!3_S#_AJCQ=_T+?A[_OK4_P#Y*H_MN?\ SZ7_ ),'^NN+_P"@>E_X
M%/\ S#_AJCQ=_P!"WX>_[ZU/_P"2J/[;G_SZ7_DP?ZZXO_H'I?\ @4_\P_X:
MH\7?]"WX>_[ZU/\ ^2J/[;G_ ,^E_P"3!_KKB_\ H'I?^!3_ ,P_X:H\7?\
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M?A[_ +ZU/_Y*H_MN?_/I?^3!_KKB_P#H'I?^!3_S#_AJCQ=_T+?A[_OK4_\
MY*H_MN?_ #Z7_DP?ZZXO_H'I?^!3_P P_P"&J/%W_0M^'O\ OK4__DJC^VY_
M\^E_Y,'^NN+_ .@>E_X%/_,/^&J/%W_0M^'O^^M3_P#DJC^VY_\ /I?^3!_K
MKB_^@>E_X%/_ ##_ (:H\7?]"WX>_P"^M3_^2J/[;G_SZ7_DP?ZZXO\ Z!Z7
M_@4_\P_X:H\7?]"WX>_[ZU/_ .2J/[;G_P ^E_Y,'^NN+_Z!Z7_@4_\ ,/\
MAJCQ=_T+?A[_ +ZU/_Y*H_MN?_/I?^3!_KKB_P#H'I?^!3_S#_AJCQ=_T+?A
M[_OK4_\ Y*H_MN?_ #Z7_DP?ZZXO_H'I?^!3_P P_P"&J/%W_0M^'O\ OK4_
M_DJC^VY_\^E_Y,'^NN+_ .@>E_X%/_,/^&J/%W_0M^'O^^M3_P#DJC^VY_\
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M3!_KKB_^@>E_X%/_ ##_ (:H\7?]"WX>_P"^M3_^2J/[;G_SZ7_DP?ZZXO\
MZ!Z7_@4_\P_X:H\7?]"WX>_[ZU/_ .2J/[;G_P ^E_Y,'^NN+_Z!Z7_@4_\
M,/\ AJCQ=_T+?A[_ +ZU/_Y*H_MN?_/I?^3!_KKB_P#H'I?^!3_S#_AJCQ=_
MT+?A[_OK4_\ Y*H_MN?_ #Z7_DP?ZZXO_H'I?^!3_P P_P"&J/%W_0M^'O\
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M_P#DZCZKA_\ GTOQ#^P,I_Z!?_)O^ '_  HKX5?]"C9?^!6I_P#R=1]5P_\
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MB']@93_T"_\ DW_ #_A17PJ_Z%&R_P# K4__ ).H^JX?_GTOQ#^P,I_Z!?\
MR;_@!_PHKX5?]"C9?^!6I_\ R=1]5P__ #Z7XA_8&4_] O\ Y-_P _X45\*O
M^A1LO_ K4_\ Y.H^JX?_ )]+\0_L#*?^@7_R;_@!_P **^%7_0HV7_@5J?\
M\G4?5</_ ,^E^(?V!E/_ $"_^3?\ /\ A17PJ_Z%&R_\"M3_ /DZCZKA_P#G
MTOQ#^P,I_P"@7_R;_@!_PHKX5?\ 0HV7_@5J?_R=1]5P_P#SZ7XA_8&4_P#0
M+_Y-_P  /^%%?"K_ *%&R_\  K4__DZCZKA_^?2_$/[ RG_H%_\ )O\ @!_P
MHKX5?]"C9?\ @5J?_P G4?5</_SZ7XA_8&4_] O_ )-_P _X45\*O^A1LO\
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MOA5_T*-E_P"!6I__ "=1]5P__/I?B']@93_T"_\ DW_ #_A17PJ_Z%&R_P#
MK4__ ).H^JX?_GTOQ#^P,I_Z!?\ R;_@!_PHKX5?]"C9?^!6I_\ R=1]5P__
M #Z7XA_8&4_] O\ Y-_P _X45\*O^A1LO_ K4_\ Y.H^JX?_ )]+\0_L#*?^
M@7_R;_@!_P **^%7_0HV7_@5J?\ \G4?5</_ ,^E^(?V!E/_ $"_^3?\ /\
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M3_\ DZCZKA_^?2_$/[ RG_H%_P#)O^ '_"BOA5_T*-E_X%:G_P#)U'U7#_\
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-LO+O^@;_ ,F_^U/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
